Characterization of Endogenous Protoporphyrin IX Induced by δ-Aminolevulinic Acid in Resting and Activated Peripheral Blood Lymphocytes by Four-Color Flow Cytometry

Photochemistry and Photobiology

Volumn 67, Issue 5, 1998, Pages 565-572

  Hryhorenko, Eric A ^a,b   Rittenhouse Diakun, Kate ^a,b   Harvey, Nishikant S ^a   Morgan, Janet ^a   Stewart, Carleton C ^a   Oseroff, Allan R ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; PROTOPORPHYRIN; TRANSFERRIN RECEPTOR;

ARTICLE; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; METABOLISM; METHODOLOGY;

AMINOLEVULINIC ACID; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; PROTOPORPHYRINS; RECEPTORS, TRANSFERRIN;

EID: 0032058983     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-1097.1998.tb09456.x     Document Type: Article

References (32)

1. Thomson, A. W. and T. E. Starzl (1993) New immunosuppressive drugs: mechanistic insights and potential therapeutic advances. Immunol. Rev. 136, 71-98.
2. Waters, C. A., P. A. Schimke, C. E. Snider, K. Itoh, K. A. Smith, J. C. Nichols, T. B. Strom and J. R. Murphy (1990) Interleukin 2 receptor-targeted cytotoxicity. Receptor binding requirements for entry of a diphtheria toxin-related interleukin 2 fusion protein into cells. Eur. J. Immunol. 20, 785-791.
3. Rittenhouse-Diakun, K., H. van Leengoed, J. Morgan, E. A. Hryhorenko, G. Paszkiewicz, J. E. Whitaker and A. R. Oseroff (1995) The role of the transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-aminolevulinic acid (ALA). Photochem. Photobiol. 61, 523-527.
4. Modestus, O. K., A. J. Obochi, A. K. Canaan, A. M. Richter and J. G. Levy (1995) Targetting activated lymphocytes with photodynamic therapy: susceptibility of mitogen-stimulated splenic lymphocytes to benzoporphyrin derivative (BPD) photosensitization. Photochem. Photobiol. 62, 169-175.
5. Chowdhary, R. K., L. G. Ratkay, H. C. Neyndorff, A. Richter, M. Obochi, J. D. Waterfield and J. G. Levy (1994) The use of transcutaneous photodynamic therapy in the prevention of adjuvent-enhanced arthritis in MRL/lpr mice. Clin. Immunol. Immunopathol. 72, 255-263.
6. Girotti, A. W. (1990) Photodynamic lipid peroxidation in biological systems. Photochem. Photobiol. 51, 497-509.
7. Perlin, D. S., R. S. Murant, S. L. Gibson and R. Hilf (1985) Effects of photosensitization by hematoporphyrin derivative on mitochondrial adenosine triphosphatase-mediated proton transport and membrane integrity of R3230AC mammary adenocarcinoma. Cancer Res. 45, 653-658.
8. Salet, C. and G. Moreno (1990) Photosensitization of mitochondria. Molecular and cellular aspects. J. Photochem. Photobiol. B Biol. 5, 133-150.
9. Barrett, K. E., A. Yen, T. D. Bigby, D. Montisano and I. Gigli (1994) Inhibition of human peripheral blood lymphocyte function by protoporphyrin and longwave ultraviolet light. J. Immunol. 153, 3286-3294.
10. Agarwal, M. L., M. E. Clay, E. J. Harvey, H. H. Evans, A. R. Antunez and N. L. Oleinick (1991) Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Res. 51, 5993-5996.
11. Oseroff, A. R., D. Ohuoha, G. Ara, D. McAuliffe, J. Foley and L. Cincotta (1986) Intramitochondrial dyes allow selective in vitro photolysis of carcinoma cells. Proc. Natl. Acad. Sci. USA 83, 9729-9733.
12. Pass, H. I. (1993) Photodynamic therapy in oncology: mechanisms and clinical use. J. Natl. Cancer Inst. 85, 443-456.
13. Dougherty, T. J. and S. L. Marcus (1992) Photodynamic therapy. Eur. J. Cancer 28A, 1734-1742.
14. Kennedy, J. C., R. H. Pottier and D. C. Pross (1990) Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experiments. J. Photochem. Photobiol. B Biol. 6, 143-148.
15. He, D., S. Sassa and H. W. Lim (1993) Effect of UVA and blue light on porphyrin biosynthesis in epidermal cells. J. Photochem. Photobiol. B Biol. 57, 825-829.
16. Stewart, C. C. and S. J. Stewart (1994) Cell preparation for the identification of leukocytes. Methods Cell Biol. 41, 39-60.
17. Stewart, C. C. and S. J. Stewart (1994) Multiparameter analysis of leukocytes by flow cytometry. Methods Cell Biol. 41, 61-79.
18. Brun, A., H. B. Steen and S. Sanberg (1988) Erythropoietic protoporphyria: a quantitative determination of erythrocyte protoporphyrin in individual cells by flow cytometry. Scand. J. Clin. Lab. Invest. 48, 261-267.
19. Schleiffenbaum, B. E., E. I. Miner, P. Mohr, M. Decurtins and A. Schaffner (1992) Cytofluorometry as a diagnosis of protoporphyria. Gastroenterology 102, 1044-1048.
20. Malik, Z., B. Ehrenberg and A. Faragg (1989) Inactivation of erythrocytic, lymphocytic and myelocytic leukemic cells by photoactivation of endogenous porphyrins. J. Photochem. Photobiol. B Biol. 4, 195-205.
21. Krammer, B. and K. Überriegler (1996) In vitro investigation of ALA-induced protoporphyrin IX. J. Photochem. Photobiol. B Biol. 36, 121-126.
22. Vonarx-Coinsman, V., M. T. Foultier, L. Xavier de Brito, L. Morlet, A. Gouyette and T. Patrice (1995) HepG2 human hepatocarcinoma cells: an experimental model for photosensitization by endogenous porphyrins. J. Photochem. Photobiol. B Biol. 30, 201-208.
23. Ortel, B., A. Tanew and H. Honigsmann (1993) Lethal photosensitization by endogenous porphyrins of PAM cells - modification by desferrioxamine. J. Photochem. Photobiol. B Biol. 17, 273-278.
24. Malik, Z., G. Kostenich, L. Roitman, B. Ehrenberg and A. Orenstein (1995) Topical application of 5-aminolevulinic acid, DMSO and EDTA: protoporphyrin IX accumulation in skin and tumours of mice. J. Photochem. Photobiol. B Biol. 28, 213-218.
25. Berg, K., H. Anholt, O. Bech and J. Moan (1996) The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells. Br. J. Cancer 74, 688-697.
26. Korhelik, M. and G. Krosl (1996) Photofrin accumulation in malignant and host cell populations of various tumours. Br. J. Cancer 73, 506-513.
27. Korbelik, M. and G. Krosl. (1995) Accumulation of benzo-porphyrin derivative in malignant and host cell populations of the murine RIF tumor. Cancer Lett. 97, 249-254.
28. Ullrich, S. E., J. Alcalay, L. Applegate and M. L. Kripke (1989) Immunosuppression in phototherapy. Ciba Found. Symp. 146, 131-139.
29. North, J., H. Neyndorff and J. G. Levy (1993) Photosensitizers as virucidal agents. J. Photochem. Photobiol. B Biol. 17, 99-108.
30. Grant, W. E., C. Hopper, A. J. MacRobert, P. M. Speight and S. G. Bown (1993) Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid. Lancet 342, 147-148.
31. Fromm, D., D. Kessel and J. Webber (1996) Feasibility of photodynamic therapy using endogenous photosensitization for colon cancer. Arch. Surg. 131, 667-669.
32. Anderson, R. R. and J. A. Parrish (1981) The optics of human skin. J. Invest. Dermatol. 77, 13.